Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -19.63% | 6.96% | 6.97% | 7.20% | 265.67% |
| Total Other Revenue | 0.09% | -4.26% | -8.82% | -9.65% | -5.14% |
| Total Revenue | -0.22% | -4.09% | -8.59% | -9.40% | -4.04% |
| Cost of Revenue | -6.40% | -4.62% | -3.31% | 5.08% | 7.48% |
| Gross Profit | 32.63% | -1.68% | -27.63% | -49.66% | -38.85% |
| SG&A Expenses | 2.13% | 15.01% | 25.93% | 37.55% | 44.56% |
| Depreciation & Amortization | -2.48% | -8.65% | -7.44% | -7.07% | -6.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.06% | -0.07% | 3.18% | 11.88% | 14.42% |
| Operating Income | 23.98% | -29.36% | -167.54% | -3,025.39% | -44,747.27% |
| Income Before Tax | -116.62% | -387.47% | -744.74% | -65.75% | -28.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -116.62% | -387.47% | -744.74% | -65.75% | -28.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.62% | -387.47% | -744.74% | -65.75% | -28.31% |
| EBIT | 23.98% | -29.36% | -167.54% | -3,025.39% | -44,747.27% |
| EBITDA | 30.29% | -48.48% | -454.21% | -584.28% | -421.47% |
| EPS Basic | -114.95% | -378.36% | -764.33% | -64.94% | -20.21% |
| Normalized Basic EPS | 19.79% | -14.30% | -90.85% | -355.56% | -334.65% |
| EPS Diluted | -114.97% | -374.92% | -769.02% | -63.30% | -18.80% |
| Normalized Diluted EPS | 19.79% | -14.30% | -90.85% | -355.56% | -334.65% |
| Average Basic Shares Outstanding | 0.31% | 0.20% | 0.10% | 0.01% | 1.72% |
| Average Diluted Shares Outstanding | 0.31% | 0.20% | 0.10% | 0.01% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | 1.00% | -1.00% | 0.86% | 0.50% |
